BSX - Boston Scientific succeeds in pivotal trial for leadless pacemaker
2024-05-18 11:58:26 ET
More on Boston Scientific
- Boston Scientific Corporation (BSX) Q1 2024 Earnings Call Transcript
- Boston Scientific Corporation 2024 Q1 - Results - Earnings Call Presentation
- Boston Scientific: Implications Of The Axonics-Medtronic Patent Clash
- Boston Scientific hits 52-week high on Q1 beat
- Boston Scientific Non-GAAP EPS of $0.56 beats by $0.05, revenue of $3.86B beats by $180M